Ramesh Indrakanti, PhDBiologics Product Specialist/Senior Account Manager at Phenomenex
Dr. Ramesh Indrakanti is a Biologics Product Specialist and Senior Account Manager at Phenomenex. He has over 18 years of experience in chromatography and mass spectrometry of biomolecules, obtained in industry and academia. His previous experience includes positions at Intellia Therapeutics (2019-2020), Alnylam Pharmaceuticals (2015-2019) and Massachusetts Institute of Technology (2007-2015). In these roles, Dr. Indrakanti supported the development of drug modalities such as LNP-based CRISPR/Cas9 gene editing (Intellia) and siRNA drug metabolism (Alnylam), and contributed to the fundamental understanding of codon-biased translational regulation (MIT).
Dr. Indrakanti obtained his Ph.D. in Chemistry from the National Chemical Laboratory (India) in 2002 and conducted his post-doctoral studies on the biophysical characterization of fluorinated peptides at Tufts University (2002-2005), followed by proteomics-based analysis of effects of lymphoma in SJL mouse models at the Massachusetts Institute of Technology (2005-2007).